Do they actually negotiate deals with insurance companies where they lose money on some procedures?
If they don't, then the problem is that they want the revenue from the higher paying insurance, not worries over fraud.
If they don't, then the problem is that they want the revenue from the higher paying insurance, not worries over fraud.
"Insurance companies won't play the game that way" is sort of an answer, but it isn't very satisfying.
I guess fraud statutes might benefit from some rules about the ratio between average negotiated prices and stated prices (I'm a little uncomfortable telling entities how they are allowed to price things, but large medical institutions clearly have some dysfunction in this area).